All public logs
Jump to navigation
Jump to search
Combined display of all available logs of Wikibase.slis.ua.edu. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)- 14:59, 20 May 2020 Maintenance script talk contribs created page Ajani JA, et al. Semin. Oncol. (2015) cited as Ref 11 in DOI: 10.1038/s41392-020-0110-5
- 14:59, 20 May 2020 Maintenance script talk contribs created page Visvader JE, et al. Cell Stem Cell (2012) cited as Ref 10 in DOI: 10.1038/s41392-020-0110-5
- 14:59, 20 May 2020 Maintenance script talk contribs created page Shibata M, et al. Cancers (2019) cited as Ref 9 in DOI: 10.1038/s41392-020-0110-5
- 14:59, 20 May 2020 Maintenance script talk contribs created page Shimokawa M, et al. Nature (2017) cited as Ref 8 in DOI: 10.1038/s41392-020-0110-5
- 14:59, 20 May 2020 Maintenance script talk contribs created page Bonnet D, et al. Nat. Med. (1997) cited as Ref 7 in DOI: 10.1038/s41392-020-0110-5
- 14:59, 20 May 2020 Maintenance script talk contribs created page Lapidot T, et al. Nature (1994) cited as Ref 6 in DOI: 10.1038/s41392-020-0110-5
- 14:59, 20 May 2020 Maintenance script talk contribs created page Chen W, et al. Stem Cells Int. (2016) cited as Ref 5 in DOI: 10.1038/s41392-020-0110-5
- 14:59, 20 May 2020 Maintenance script talk contribs created page Reya T, et al. Nature (2001) cited as Ref 4 in DOI: 10.1038/s41392-020-0110-5
- 14:59, 20 May 2020 Maintenance script talk contribs created page Batlle E, et al. Nat. Med. (2017) cited as Ref 3 in DOI: 10.1038/s41392-020-0110-5
- 14:59, 20 May 2020 Maintenance script talk contribs created page Sun Y, et al. Med. Res. Rev. (2015) cited as Ref 2 in DOI: 10.1038/s41392-020-0110-5
- 14:59, 20 May 2020 Maintenance script talk contribs created page Siegel RL, et al. CA Cancer J. Clin. (2019) cited as Ref 1 in DOI: 10.1038/s41392-020-0110-5
- 11:46, 20 May 2020 Maintenance script talk contribs created page Competing interests (from DOI: 10.1038/s41392-020-0110-5)
- 11:46, 20 May 2020 Maintenance script talk contribs created page Section 5: Conclusions and perspectives (from DOI: 10.1038/s41392-020-0110-5)
- 11:46, 20 May 2020 Maintenance script talk contribs created page Section 4.4: CSC-directed immunotherapy (from DOI: 10.1038/s41392-020-0110-5)
- 11:46, 20 May 2020 Maintenance script talk contribs created page Section 4.3: Targeting the CSC microenvironment (from DOI: 10.1038/s41392-020-0110-5)
- 11:46, 20 May 2020 Maintenance script talk contribs created page Section 4.2: Agents targeting CSC-associated signaling pathways in clinical trials (from DOI: 10.1038/s41392-020-0110-5)
- 11:46, 20 May 2020 Maintenance script talk contribs created page Section 4.1: Agents targeting CSC-associated surface biomarkers in clinical trials (from DOI: 10.1038/s41392-020-0110-5)
- 11:46, 20 May 2020 Maintenance script talk contribs created page Section 4: Therapeutic targeting of CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 11:46, 20 May 2020 Maintenance script talk contribs created page Section 3.3.7: Exosomes in the TME and CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 11:46, 20 May 2020 Maintenance script talk contribs created page Section 3.3.6: Extracellular matrix and CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 11:46, 20 May 2020 Maintenance script talk contribs created page Section 3.3.5: Cancer-associated MSCs and CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 11:46, 20 May 2020 Maintenance script talk contribs created page Section 3.3.4: Cancer-associated fibroblasts and CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 11:46, 20 May 2020 Maintenance script talk contribs created page Section 3.3.3: Tumor-associated macrophages and CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 11:46, 20 May 2020 Maintenance script talk contribs created page Section 3.3.2: The hypoxia microenvironment and CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 11:46, 20 May 2020 Maintenance script talk contribs created page Section 3.3.1: Vascular niche microenvironments and CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 11:46, 20 May 2020 Maintenance script talk contribs created page Section 3.3: The microenvironment of CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 11:46, 20 May 2020 Maintenance script talk contribs created page Section 3.2.9: Interactions between signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 11:46, 20 May 2020 Maintenance script talk contribs created page Section 3.2.8: PPAR signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 11:46, 20 May 2020 Maintenance script talk contribs created page Section 3.2.7: PI3K/AKT/mTOR signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 11:46, 20 May 2020 Maintenance script talk contribs created page Section 3.2.6: TGF/SMAD signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 11:46, 20 May 2020 Maintenance script talk contribs created page Section 3.2.5: JAK-STAT signaling pathway (from DOI: 10.1038/s41392-020-0110-5)
- 11:46, 20 May 2020 Maintenance script talk contribs created page Section 3.2.4: NF-kappaB signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 11:46, 20 May 2020 Maintenance script talk contribs created page Section 3.2.3: Hh signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 11:46, 20 May 2020 Maintenance script talk contribs created page Section 3.2.2: Notch signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 11:46, 20 May 2020 Maintenance script talk contribs created page Section 3.2.1: Wnt signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 11:46, 20 May 2020 Maintenance script talk contribs created page Section 3.2: Major signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 11:46, 20 May 2020 Maintenance script talk contribs created page Section 3.1: Major transcription factors in CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 11:46, 20 May 2020 Maintenance script talk contribs created page Section 3: Factors regulating CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 11:46, 20 May 2020 Maintenance script talk contribs created page Section 2.2: Isolation and identification of CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 11:46, 20 May 2020 Maintenance script talk contribs created page Section 2.1: Biological characteristics of CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 11:45, 20 May 2020 Maintenance script talk contribs created page Section 2: The concept of CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 21:47, 19 May 2020 Maintenance script talk contribs created page Competing interests (from DOI: 10.1038/s41392-020-0110-5)
- 21:46, 19 May 2020 Maintenance script talk contribs created page Section 5: Conclusions and perspectives (from DOI: 10.1038/s41392-020-0110-5)
- 21:46, 19 May 2020 Maintenance script talk contribs created page Section 4.4: CSC-directed immunotherapy (from DOI: 10.1038/s41392-020-0110-5)
- 21:46, 19 May 2020 Maintenance script talk contribs created page Section 4.3: Targeting the CSC microenvironment (from DOI: 10.1038/s41392-020-0110-5)
- 21:46, 19 May 2020 Maintenance script talk contribs created page Section 4.2: Agents targeting CSC-associated signaling pathways in clinical trials (from DOI: 10.1038/s41392-020-0110-5)
- 21:46, 19 May 2020 Maintenance script talk contribs created page Section 4.1: Agents targeting CSC-associated surface biomarkers in clinical trials (from DOI: 10.1038/s41392-020-0110-5)
- 21:46, 19 May 2020 Maintenance script talk contribs created page Section 4: Therapeutic targeting of CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 21:46, 19 May 2020 Maintenance script talk contribs created page Section 3.3.7: Exosomes in the TME and CSCs (from DOI: 10.1038/s41392-020-0110-5)
- 21:46, 19 May 2020 Maintenance script talk contribs created page Section 3.3.6: Extracellular matrix and CSCs (from DOI: 10.1038/s41392-020-0110-5)
